DRMAW — Dermata Therapeutics Inc. Warrant
NASDAQ
$0.00
-$0.00 (-50.00%)
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ. It is led by Gerald T. Proehl, based in 3525 Del Mar Heights Rd., San Diego, CA, United States, 92130, with about 9 employees. Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Net income was -$1.7M.
Use this DRMAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DRMAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DRMAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Dermata Therapeutics Inc. Warrant even when a live quote feed is slow.
About Dermata Therapeutics Inc. Warrant
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
DRMAW Key Statistics
Market Cap
$0.00M
Volume
146,059
Previous Close
$0.00
Day Range
$0.00 – $0.00
EPS
-$8.03
Revenue
$0.00
Net Income
-$12.29M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
9
DRMAW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$12.29M | -$7.79M | -$9.61M |
| EPS (Diluted) | -$8.03 | -$39.99 | $0.00 |
Total Assets
$3.53M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$0.00
Operating Cash Flow
-$11.16M
Free Cash Flow
$0.00
Dermata Therapeutics Inc. Warrant Company Information
- Founder, President, CEO & Chairman
- Gerald T. Proehl
- Headquarters
- 3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
- Website
- www.dermatarx.com
- Phone
- 858 800 2543
- IPO / Founded
- 2021-08-13